AbbVie
ABBV
ABBV
1,994 hedge funds and large institutions have $99B invested in AbbVie in 2018 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 819 increasing their positions, 831 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,994
Holders Change
-19
Holders Change %
-0.94%
% of All Funds
45.71%
Holding in Top 10
127
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-7.3%
% of All Funds
2.91%
New
81
Increased
819
Reduced
831
Closed
82
Calls
$984M
Puts
$1.33B
Net Calls
-$349M
Net Calls Change
-$61.6M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
$1.11B |
| 2 |
Millennium Management
New York
|
$251M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$160M |
| 4 |
ATN
AMF Tjänstepension
Stockholm,
Sweden
|
$113M |
| 5 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
$1.36B |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$661M |
| 2 |
Jennison Associates
New York
|
$20.6M |
| 3 |
BlackRock
New York
|
$8.91B |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
$284M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$10.9B |
